134 related articles for article (PubMed ID: 18672226)
1. Study of macular function by multifocal electroretinography in patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Fang W; Wang L; Wen F; Wu W; Kijlstra A
Am J Ophthalmol; 2008 Nov; 146(5):767-71. PubMed ID: 18672226
[TBL] [Abstract][Full Text] [Related]
2. Visual function in Vogt-Koyanagi-Harada patients.
Chee SP; Luu CD; Cheng CL; Lim WK; Jap A
Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):785-90. PubMed ID: 15761760
[TBL] [Abstract][Full Text] [Related]
3. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
4. Retinal functional changes measured by microperimetry after immunosuppressive therapy in patients with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Al-Mezaine HS; Hemachandran S; Hariz R; Kangave D
Eur J Ophthalmol; 2012; 22(3):368-75. PubMed ID: 21928252
[TBL] [Abstract][Full Text] [Related]
5. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
Nakamura T; Hayashi A; Oiwake T
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):387-394. PubMed ID: 29264653
[TBL] [Abstract][Full Text] [Related]
6. Associations between functional and structural measurements in non-acute Vogt-Koyanagi-Harada disease.
Souto FMS; Missaka RFBG; Lavezzo MM; Mayumi Sakata V; Oyamada MK; Hirata CE; Yamamoto JH
Acta Ophthalmol; 2021 Aug; 99(5):e715-e723. PubMed ID: 33124155
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Study of Visual Function in Vogt-Koyanagi-Harada Disease Using Full-Field Electroretinography.
Yuan W; Zhou C; Cao Q; Du Z; Hu R; Wang Y; Kijlstra A; Yang P
Am J Ophthalmol; 2018 Jul; 191():92-99. PubMed ID: 29702075
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
Quek DT; Jap A; Chee SP
Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
[TBL] [Abstract][Full Text] [Related]
9. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration.
Parisi V; Perillo L; Tedeschi M; Scassa C; Gallinaro G; Capaldo N; Varano M
Retina; 2007 Sep; 27(7):879-90. PubMed ID: 17891012
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
12. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
Paredes I; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
15. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Yang P; Ye Z; Du L; Zhou Q; Qi J; Liang L; Wu L; Wang C; Kijlstra A
Curr Eye Res; 2018 Feb; 43(2):254-261. PubMed ID: 29111815
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
Fang W; Zhou H; Yang P; Huang X; Wang L; Kijlstra A
Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
Chee SP; Jap A; Bacsal K
Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
[TBL] [Abstract][Full Text] [Related]
19. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
Zhang M; Liu Q; Min H; Du H; Hu T
Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
Bordaberry MF
Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
